Exyn Technologies Pioneers Drone Software for GPS-denied Environments
Exyn Technologies, a PCI Ventures portfolio company focused on multi-platform robotic autonomy, is receiving global recognition for its groundbreaking drone software.
Nia Therapeutics Raises $8.5 Million
Penn spinout Nia Therapeutics recently raised $8.5 million in an equity financing round.
2024 President’s Innovation Prize Winning Team Focused on Making Life Easier for Students with Learning Differences
The President's Innovation Prize was recently awarded to fourth year Penn Engineering students for their project Jochi.
Capstan raises $175M Series B
Proceeds from the financing will be used to advance Capstan's lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, CPTX2309, to early clinical proof-of-concept in autoimmune disorders.
iEcure Gains FDA approval to Conduct FirstGene Therapy Treatment
Utilizing ARCUS, a gene editing tool developed by Precision BioSciences, the therapy aims to provide a lifelong fix for this disease, potentially benefiting thousands of individuals in the US alone.
Penn Researchers Discover New Technique to Form Human Artificial Chromosomes
Researchers at Penn led by Ben Black, PhD, the Eldridge Reeves Johnson Foundation Professor of Biochemistry and Biophysics, have found a new way to create synthetic chromosomes.
Penn Engineering Announces the First Ivy League Undergraduate Degree Program in Artificial Intelligence
Penn Engineering has introduced its Bachelor of Science in Engineering in Artificial Intelligence (AI) degree, which is the first undergraduate major of its kind among Ivy League universities.
Philly Nonprofit Awarded $48 Million to Apply AI in Search for New Uses for Approved Drugs
AI based on specific algorithms will scan tens of thousands of approved medications and rare diseases to find potential matches.
Penn Leaders Featured in the Philadelphia Business Journal’s Power 100 List
PCI congratulates these Penn leaders for their inclusion in the Philadelphia Business Journal's list of "100 business leaders set to shape Philadelphia in 2024."
Scout Bio Acquired by Leading Animal Health Company
French company Ceva Santé Animale announced that it is acquiring Scout Bio.